Company intelligence / Profile preview

Zhejiang Huahai Pharmaceutical Co., Ltd.

Linhai, Zhejiang Province, Chinaen.huahaipharm.com ↗

Ownership: Private
Employees: ~8221
Development stage: Phase 3

Overview

The company has over 10 products in clinical research stages, including an IL-36R monoclonal antibody for generalized pustular psoriasis in Phase III trials, an IL-17A monoclonal antibody in clinical trials, and a PD-L1/VEGF dual antibody in Phase II trials showing positive efficacy signals in treating multiple cancers.

Therapeutic areas: OncologyDermatologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculesBiologics (monoclonal antibodies)
Industry: Biotech

Drug pipeline

4 assets

HB0028

3 more assets in the full pipeline.

Request access →

Partnerships

Over 800 cooperative partners

Beyond the preview

Go deeper on Zhejiang Huahai Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhejiang Huahai Pharmaceutical Co., Ltd..

Explore the full profile